TGFBR2 and breast carcinoma: Several studies have demonstrated that tumor cell autonomous genetic inactivation of the TGF-β signaling pathway by knock-down of TGFBR2 or SMAD4 reduced the ability of MDA-MB-231 human basal-like breast cancer cells to metastasize to bone [23,25-27].